rs73238708
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_021957.4(GYS2):c.1423-21A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0038 in 1,551,594 control chromosomes in the GnomAD database, including 72 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 35 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 37 hom. )
Consequence
GYS2
NM_021957.4 intron
NM_021957.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.572
Genes affected
GYS2 (HGNC:4707): (glycogen synthase 2) The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 12-21546491-T-C is Benign according to our data. Variant chr12-21546491-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 261467.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0124 (1877/151414) while in subpopulation AFR AF= 0.037 (1525/41234). AF 95% confidence interval is 0.0354. There are 35 homozygotes in gnomad4. There are 880 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 35 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GYS2 | NM_021957.4 | c.1423-21A>G | intron_variant | ENST00000261195.3 | NP_068776.2 | |||
GYS2 | XM_006719063.4 | c.1192-21A>G | intron_variant | XP_006719126.1 | ||||
GYS2 | XM_024448960.2 | c.1423-21A>G | intron_variant | XP_024304728.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GYS2 | ENST00000261195.3 | c.1423-21A>G | intron_variant | 1 | NM_021957.4 | ENSP00000261195 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0124 AC: 1873AN: 151300Hom.: 35 Cov.: 32
GnomAD3 genomes
AF:
AC:
1873
AN:
151300
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00499 AC: 1030AN: 206216Hom.: 10 AF XY: 0.00418 AC XY: 465AN XY: 111346
GnomAD3 exomes
AF:
AC:
1030
AN:
206216
Hom.:
AF XY:
AC XY:
465
AN XY:
111346
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00288 AC: 4026AN: 1400180Hom.: 37 Cov.: 24 AF XY: 0.00285 AC XY: 1982AN XY: 696554
GnomAD4 exome
AF:
AC:
4026
AN:
1400180
Hom.:
Cov.:
24
AF XY:
AC XY:
1982
AN XY:
696554
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0124 AC: 1877AN: 151414Hom.: 35 Cov.: 32 AF XY: 0.0119 AC XY: 880AN XY: 73962
GnomAD4 genome
AF:
AC:
1877
AN:
151414
Hom.:
Cov.:
32
AF XY:
AC XY:
880
AN XY:
73962
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
19
AN:
3474
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 26, 2021 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at